Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children - 09/12/18
, Giovanni Delogu aSummary |
Objectives |
Interferon-γ release assays (IGRA) are designed for diagnosis of tuberculosis (TB) infection, and do not discriminate latent TB infection (LTBI) from active TB. Heparin-binding hemagglutinin antigen (HBHA) emerged as a promising antigen for TB diagnosis when used in IGRA format. Aim of this study was to prospectively evaluate the performance of an HBHA-based IGRA to support TB diagnosis and TB therapy monitoring in children with TB infection or active TB disease.
Methods |
Following clinical, microbiological and radiological assessment, children (0–14 years old) were tested by the QuantiFERON TB-Gold In tube (QFT) assay and an aliquot of whole-blood was stimulated with HBHA and IFNγ evaluated only in QFT-positive subjects.
Results |
Among the 550 children tested, 486 (88.4%) scored negative and 64 (11.6%) positive. None of the QFT-negative had active TB. Among the QFT-positive, 45 were with LTBI and 19 active TB. HBHA-IGRA scored positive in 41/45 children (91.1%) with LTBI and in 6/19 active TB children (31.6%) at diagnosis (p = 0.001); remarkably, 5 of these 6 children with active TB scoring HBHA-positive were asymptomatic. Moreover, following TB-specific therapy, most of the non-HBHA-responding children, gained an HBHA-positive response.
Conclusions |
HBHA-based IGRA is a useful support in TB diagnosis and TB-therapy monitoring in children.
Le texte complet de cet article est disponible en PDF.Keywords : Tuberculosis, Children, IGRA, HBHA, Monitoring of therapy, Quantiferon, Biomarkers
Plan
Vol 77 - N° 6
P. 526-533 - décembre 2018 Retour au numéro
Article précédent
- Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care
- Kate Nambiar, Harald Seifert, Siegbert Rieg, Winfried V. Kern, Matt Scarborough, N. Claire Gordon, Hong Bin Kim, Kyoung-Ho Song, Robert Tilley, Hannah Gott, Chun-Hsing Liao, Jonathan Edgeworth, Emmanuel Nsutebu, Luis Eduardo López-Cortés, Laura Morata, A. Sarah Walker, Guy Thwaites, Martin J. Llewelyn, Achim J. Kaasch, International Staphylococcus aureus collaboration (ISAC) study group (with linked authorship to members in the Acknowledgements) and the ESCMID Study Group for Bloodstream Infections and Sepsis (ESGBIS), Marina de Cueto, Isabel Morales, Jesús Rodríguez-Baño, Eu Suk Kim, Chung-Jong Kim, Chang Kyung Kang, Jung In Park, Christian Bernasch, Danuta Stefanik, Norma Jung, Martin Hellmich, Peter Wilson, Anna Reyes, Saadia Rahman, Victoria Dean, Miguel Marcos, Hugo Guillermo Ternavasio-de la Vega, Estée Török, Theodore Gouliouris, Luke Bedford, José L. Pérez, Enrique Ruiz de Gopegui, Maria Luisa Martín-Pena, Susan Hopkins, Karuna Lamarca, Beatriz Mirelis, Mercedes Gurgui Ferrer, Vance G. Fowler, Felicia Ruffin, José Miguel Cisneros Herreros, José A. Lepe, Cristina Roca, James R. Price, Angela Dunne, Laura Behar, Gavin Barlow
- Genomes of Escherichia coli bacteraemia isolates originating from urinary tract foci contain more virulence-associated genes than those from non-urinary foci and neutropaenic hosts
- Adam P. Dale, Anish K. Pandey, Richard J. Hesp, Konstantinos Belogiannis, Jay R. Laver, Clifford C. Shone, Robert C. Read
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?